No connection

Search Results

ABBV vs CCM

ABBV
AbbVie Inc.
NEUTRAL
Price
$219.26
Market Cap
$387.52B
Sector
Healthcare
AI Confidence
68%
CCM
Concord Medical Services Holdings Limited
BEARISH
Price
$4.00
Market Cap
$17.4M
Sector
Healthcare
AI Confidence
95%

Valuation

P/E Ratio
ABBV
163.63
CCM
--
Forward P/E
ABBV
15.42
CCM
-26.67
P/B Ratio
ABBV
-146.66
CCM
-0.05
P/S Ratio
ABBV
6.5
CCM
0.05
EV/EBITDA
ABBV
15.27
CCM
-22.79

Profitability

Gross Margin
ABBV
71.46%
CCM
-11.44%
Operating Margin
ABBV
35.5%
CCM
-72.1%
Profit Margin
ABBV
4.0%
CCM
-44.6%
ROE
ABBV
137.96%
CCM
-29.03%
ROA
ABBV
9.59%
CCM
-4.48%

Growth

Revenue Growth
ABBV
9.1%
CCM
-8.3%
Earnings Growth
ABBV
-88.7%
CCM
--

Financial Health

Debt/Equity
ABBV
--
CCM
2.22
Current Ratio
ABBV
0.72
CCM
0.42
Quick Ratio
ABBV
0.47
CCM
0.1

Dividends

Dividend Yield
ABBV
3.05%
CCM
--
Payout Ratio
ABBV
490.15%
CCM
0.0%

AI Verdict

ABBV NEUTRAL

The Advanced Deterministic Scorecard reveals a mixed health profile with a Piotroski F-Score of 4/9 indicating stable but not strong fundamentals, while the absence of an Altman Z-Score prevents a clear distress risk assessment. Despite robust operating margins and consistent revenue growth, the company faces significant headwinds from negative earnings growth, an extremely high P/E ratio, and a dangerously elevated payout ratio. Strong historical price performance and analyst buy sentiment are counterbalanced by bearish insider activity and deteriorating profitability trends. The stock appears to trade at a substantial premium to its intrinsic value, suggesting limited margin of safety.

Strengths
High operating margin (35.50%) indicating strong pricing power and cost control
Consistent revenue growth (9.10% YoY) outpacing sector average
Strong track record of earnings surprises (22 out of 25 quarters beat estimates)
Risks
Extremely high P/E ratio (163.63) vs forward P/E (15.42), suggesting potential overvaluation on trailing basis
Earnings growth collapsing (YoY: -88.70%, Q/Q: -88.10%) indicating severe profitability deterioration
Unsustainable dividend payout ratio (490.15%) threatening dividend security
CCM BEARISH

CCM exhibits severe financial distress, anchored by a weak Piotroski F-Score of 3/9 and a critical liquidity crisis. The company suffers from negative gross margins (-11.44%), meaning it loses money on every unit of service provided before operating expenses are even considered. With a Price-to-Book ratio of -0.05, the company has negative shareholder equity, and a Quick Ratio of 0.10 indicates an inability to meet short-term obligations. Combined with declining revenue (-8.30% YoY) and a 5-year price collapse of 89%, the fundamental outlook is highly precarious.

Strengths
Extremely low Price-to-Sales ratio (0.05)
Recent short-term price recovery (+9.6% over 1 month)
Positive Q/Q EPS growth (+60.4%) though still negative in absolute terms
Risks
Negative Gross Margins indicating a fundamentally broken business model
Severe liquidity risk with a Current Ratio of 0.42 and Quick Ratio of 0.10
Negative Book Value (Price/Book -0.05) suggesting insolvency

Compare Another Pair

ABBV vs CCM: Head-to-Head Comparison

This page compares AbbVie Inc. (ABBV) and Concord Medical Services Holdings Limited (CCM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI Chat
Markets
Profile